Research Week 2017: A new approach to permanent birth control for women

By Ariane Le Chevallier May 02, 2017 Portland, Ore.

Downloads

Research Week: Jeffrey Jensen, M.D., M.P.H.

Dr. Jeffrey Jensen's research aims to use an FDA-approved treatment for varicose veins as a non-invasive, non-hormonal form of permanent contraception. (OHSU/Kristyna Wentz-Graff)

Research Week: Jeffrey Jensen, M.D., M.P.H.

Dr. Jeffrey Jensen's research aims to use an FDA-approved treatment for varicose veins as a non-invasive, non-hormonal form of permanent contraception. (OHSU/Kristyna Wentz-Graff)

Research Week: Jeffrey Jensen, M.D., M.P.H.

In animal models, a high rate of tubal occlusion and pregnancy preventions were acheived with the application of a single dose of polidocanal foam. (OHSU/Kristyna Wentz-Graff)

Research Week: Jeffrey Jensen, M.D., M.P.H.

Dr. Jeffrey Jensen's research aims to use an FDA-approved treatment for varicose veins as a non-invasive, non-hormonal form of permanent contraception. (OHSU/Kristyna Wentz-Graff)

Research Week: Jeffrey Jensen, M.D., M.P.H.

Dr. Jeffrey Jensen (left) works with patient Callista Fink during her appointment on April 18, 2017 at OHSU, as resident Emily Schloff, M.D. (right) prepares to insert a contraceptive implant. (OHSU/Kristyna Wentz-Graff)

Research Week: Jeffrey Jensen, M.D., M.P.H.

Dr. Jeffrey Jensen talks with patient Callista Fink during her appointment on April 18, 2017 at OHSU. (OHSU/Kristyna Wentz-Graff)

Research Week: Jeffrey Jensen, M.D., M.P.H.

Dr. Jeffrey Jensen's research aims to use an FDA-approved treatment for varicose veins as a non-invasive, non-hormonal form of permanent contraception. (OHSU/Kristyna Wentz-Graff)